A Massachusetts-based company has acquired the blood collection and processing business of Tucson-based Engineering and Research Associates Inc., known as SEBRA, for $12.5 million cash.
Haemonetics Corp. of Braintree, Mass., will retain the SEBRA brand and will relocate the SEBRA Blood Collection and Processing Division to its Braintree and Salt Lake City locations.
SEBRA will operate under a new company name to be announced later this year, the company said today in a news release. The acquisition is expected to close within the next several weeks.
Haemonetics provides blood collection and separation technologies, surgical blood recovery systems, information systems and consulting services to hospitals and blood-collection sites.
SEBRA markets an array of products used in blood collection and processing, including radio-frequency tube sealers, whole-blood collection devicesmobile collection and other ancillary equipment.
People are also reading…
SEBRA President and CEO Roger Vogel said in prepared remarks the sale will enable the company to expand its medical manufacturing technology products and services worldwide, including engineering consulting services and new technologies for thermal-forming, sealing and welding plastics for device manufacturing and biopharmaceutical companies.

